Comprehensive Outcomes for After Cancer Health
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This study intends to explore feasibility, acceptability, and outcomes related to the use of a digital health coaching intervention for individuals who have completed primary therapy for cancer. Up to 625 individuals with diverse cancer diagnoses will be enrolled across up to 8 clinical sites to participate in a randomized wait-list control study. Those in the intervention group will receive 6 months of digital coaching up front followed by 6 months of ongoing monitoring via patient reported and clinical outcomes, as well as wearable data. Those in the control group will be monitored via patient reported and clinical outcomes as well as wearable data for the first 6 months followed by 6 months of digital health coaching. Both groups will collect fecal microbiome samples at enrollment and month 6. The study aims to explore if and how digital health coaching may be used to enhance outcomes for individuals following completion of primary cancer therapy.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Masz zdiagnozowanego raka.
- •Zakończyłeś/aś główne leczenie raka nie wcześniej niż rok temu, lub masz raka w zaawansowanym stadium (przerzuty).
- •Masz 18 lat lub więcej.
- •Możesz przeczytać i zrozumieć zasady badania, a także wyrazić zgodę na udział.
- •Potrafisz czytać i mówić po angielsku.
- •Masz dostęp do smartfona lub tabletu, aby korzystać z aplikacji i przesyłać dane (np. z zegarka).
✗ Disqualifies
- •Masz problemy z pamięcią lub rozumowaniem, które utrudniałyby korzystanie z aplikacji lub udział w badaniu.
- •Masz inne choroby (np. neurologiczne, mięśniowo-szkieletowe), które utrudniają aktywność fizyczną.
- •Twoje przewidywane dalsze życie to mniej niż 6 miesięcy.
- •Obecnie przechodzisz aktywne leczenie z powodu nawrotu choroby nowotworowej.
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- December 11, 2024
- Sex
- No restrictions
Therapies / drugs in trial
Locations (7)
The University of Florida
Gainesville, United States
Dana Farber Cancer Institute
Boston, United States
University of Nebraska Medical Center
Omaha, United States
Memorial Sloan Kettering Cancer Center
New York, United States
The Ohio State University Wexner Medical Center
Columbus, United States
The University of Texas MD Anderson Cancer Center
Houston, United States
UT Health Houston
Houston, United States
Trial contact
Kelly J Brassil, PhD
Jennifer Loftis, DNP
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/1/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.